Anti-Thyroid Drugs Global Market Report 2025

Description

Anti-thyroid drugs are a category of medications that operate by either inhibiting the production of thyroid hormones or by reducing the effects of thyroid hormones. They are commonly prescribed for various purposes, including radioactive iodine uptake tests to evaluate thyroid function and to protect the thyroid gland in cases of radiation exposure.

The primary classes of anti-thyroid drugs include thionamides, which work by inhibiting hormone synthesis, and iodides, which inhibit hormone release. These drugs are typically administered through oral and intravenous routes and are distributed through various channels, including wholesalers, retail chains, and online distribution, among others.

The anti-thyroid drugs market research report is one of a series of new reports from The Business Research Company that provides anti-thyroid drugs market statistics, including anti-thyroid drugs industry global market size, regional shares, competitors with an anti-thyroid drugs market share, detailed anti-thyroid drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anti-thyroid drugs industry. This anti-thyroid drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti-thyroid drugs market size has grown steadily in recent years. It will grow from $2.44 billion in 2024 to $2.5 billion in 2025 at a compound annual growth rate (CAGR) of 2.2%. The growth in the historic period can be attributed to prevalence of thyroid disorders, advancements in drug development, healthcare infrastructure.

The anti-thyroid drugs market size is expected to see steady growth in the next few years. It will grow to $2.78 billion in 2029 at a compound annual growth rate (CAGR) of 2.7%. The growth in the forecast period can be attributed to patient awareness and education, healthcare expenditure, patient demographics, global economic conditions. Major trends in the forecast period include thyroid surgery and radioactive iodine alternatives, patient-centric care, telemedicine and remote monitoring.

The increasing incidence of Graves' disease, which is a leading cause of hyperthyroidism, is contributing to the growth of the anti-thyroid drugs market. Graves' disease is more prevalent in developed countries and is the most common cause of hyperthyroidism. It primarily affects individuals between the ages of 30 and 60, with women being 5-10 times more likely to develop the condition than men. Genetic factors contribute significantly to the risk of Graves' disease, with environmental factors playing a smaller role. As the number of people diagnosed with Graves' disease and hyperthyroidism rises, there is a corresponding increase in the demand for anti-thyroid drugs, thereby driving the market's growth.

The increasing prevalence of thyroid cancer is expected to drive the growth of the anti-thyroid drugs market. Thyroid cancer affects the thyroid gland, which is responsible for regulating various bodily functions. Anti-thyroid drugs play a crucial role in the early detection and management of thyroid cancer, potentially improving treatment outcomes. As the prevalence of thyroid cancer rises, the demand for diagnostic tools, including anti-thyroid drugs, increases. For instance, in 2023, an estimated 43,720 adults in the United States were diagnosed with thyroid cancer, with 2,120 expected deaths attributed to the disease. This increasing prevalence of thyroid cancer is contributing to the growth of the anti-thyroid drugs market.

Various associations dedicated to thyroid care are taking proactive steps to raise awareness about thyroid disorders, recent treatment approaches, and research findings in this field. In the United States, a significant portion of the population with hyperthyroidism remains undiagnosed, with nearly 60% unaware of their condition. Organizations like the American Thyroid Association (ATA) are playing a crucial role in educating the public about thyroid disorders, with a particular focus on hyperthyroidism. Similarly, the Thyroid Foundation of Canada is actively engaged in awareness initiatives to inform the public and foster understanding of various thyroid diseases, including hyperthyroidism. Additional associations, such as the American Academy of Otolaryngology and the British Thyroid Foundation, are also launching awareness programs and initiatives in this regard. These efforts are aimed at increasing knowledge and understanding of thyroid conditions and promoting early diagnosis and effective management.

Major companies operating in the anti-thyroid drugs market are focusing on innovating products, such as Levothyroxine Sodium Injection, to provide reliable services to customers. Levothyroxine Sodium Injection is an injection form of anti-thyroid drug used for treatment of myxedema coma which is a condition of severe hypothyroidism. For instance, in December 2022, Hikma Pharmaceuticals PLC, a UK-based pharmaceutical company, launched Levothyroxine Sodium Injection. Levothyroxine Sodium Injection is medicine used in hospitals for the treatment of thyroid disorders. It is a ready-to-use vials that benefit patients by providing a more convenient and efficient way to administer the medication in hospitals.

Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline PLC, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan PLC, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

North America was the largest region in the anti-thyroid drugs market in 2024. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the anti-thyroid drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anti-thyroid drugs market consists of sales of levothyroxine, propylthiouracil, and methimazole. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anti-Thyroid Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anti-thyroid drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anti-thyroid drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-thyroid drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis); Iodides (Inhibition Of Hormone Release)
2) By Route of Administration: Oral; Intravenous; Other Route Of Administration
3) By Distribution Channel: Wholesaler Or Distributors; Retail Chain; Online Distribution; Other Distribution Channels
Subsegments:
1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole; Propylthiouracil
2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide; Lugol's Iodine Solution
Companies Mentioned: Mylan N.V.; Abbott Laboratories; GlaxoSmithKline plc; Merck & Co.; AbbVie Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r32388

1. Executive Summary

2. Anti-Thyroid Drugs Market Characteristics

3. Anti-Thyroid Drugs Market Trends And Strategies

4. Anti-Thyroid Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Anti-Thyroid Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Anti-Thyroid Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Anti-Thyroid Drugs Market Growth Rate Analysis
5.4. Global Anti-Thyroid Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Anti-Thyroid Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Anti-Thyroid Drugs Total Addressable Market (TAM)

6. Anti-Thyroid Drugs Market Segmentation

6.1. Global Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thionamides (Inhibition Of Hormone Synthesis)
Iodides (Inhibition Of Hormone Release)
6.2. Global Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Other Route Of Administration
6.3. Global Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Wholesaler Or Distributors
Retail Chain
Online Distribution
Other Distribution Channels
6.4. Global Anti-Thyroid Drugs Market, Sub-Segmentation Of Thionamides (Inhibition Of Hormone Synthesis), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Methimazole
Propylthiouracil
6.5. Global Anti-Thyroid Drugs Market, Sub-Segmentation Of Iodides (Inhibition Of Hormone Release), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Potassium Iodide
Lugol's Iodine Solution

7. Anti-Thyroid Drugs Market Regional And Country Analysis

7.1. Global Anti-Thyroid Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Anti-Thyroid Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anti-Thyroid Drugs Market

8.1. Asia-Pacific Anti-Thyroid Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anti-Thyroid Drugs Market

9.1. China Anti-Thyroid Drugs Market Overview
9.2. China Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anti-Thyroid Drugs Market

10.1. India Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anti-Thyroid Drugs Market

11.1. Japan Anti-Thyroid Drugs Market Overview
11.2. Japan Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anti-Thyroid Drugs Market

12.1. Australia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anti-Thyroid Drugs Market

13.1. Indonesia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anti-Thyroid Drugs Market

14.1. South Korea Anti-Thyroid Drugs Market Overview
14.2. South Korea Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anti-Thyroid Drugs Market

15.1. Western Europe Anti-Thyroid Drugs Market Overview
15.2. Western Europe Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anti-Thyroid Drugs Market

16.1. UK Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anti-Thyroid Drugs Market

17.1. Germany Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anti-Thyroid Drugs Market

18.1. France Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anti-Thyroid Drugs Market

19.1. Italy Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anti-Thyroid Drugs Market

20.1. Spain Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anti-Thyroid Drugs Market

21.1. Eastern Europe Anti-Thyroid Drugs Market Overview
21.2. Eastern Europe Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anti-Thyroid Drugs Market

22.1. Russia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anti-Thyroid Drugs Market

23.1. North America Anti-Thyroid Drugs Market Overview
23.2. North America Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anti-Thyroid Drugs Market

24.1. USA Anti-Thyroid Drugs Market Overview
24.2. USA Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anti-Thyroid Drugs Market

25.1. Canada Anti-Thyroid Drugs Market Overview
25.2. Canada Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anti-Thyroid Drugs Market

26.1. South America Anti-Thyroid Drugs Market Overview
26.2. South America Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anti-Thyroid Drugs Market

27.1. Brazil Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anti-Thyroid Drugs Market

28.1. Middle East Anti-Thyroid Drugs Market Overview
28.2. Middle East Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anti-Thyroid Drugs Market

29.1. Africa Anti-Thyroid Drugs Market Overview
29.2. Africa Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anti-Thyroid Drugs Market Competitive Landscape And Company Profiles

30.1. Anti-Thyroid Drugs Market Competitive Landscape
30.2. Anti-Thyroid Drugs Market Company Profiles
- 30.2.1. Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Anti-Thyroid Drugs Market Other Major And Innovative Companies

31.1. Pfizer Inc.
31.2. Allergan plc
31.3. RLC LABS Inc.
31.4. Amgen Inc.
31.5. Lannett Company Inc.
31.6. Sanofi S.A.
31.7. Novartis AG
31.8. Teva Pharmaceutical Industries Ltd.
31.9. Eli Lilly and Company
31.10. Aspen Pharmacare Holdings Limited
31.11. Astellas Pharma Inc.
31.12. Takeda Pharmaceutical Company Limited
31.13. Boehringer Ingelheim GmbH
31.14. Daiichi Sankyo Company Limited
31.15. Roche Holding AG

32. Global Anti-Thyroid Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anti-Thyroid Drugs Market

34. Recent Developments In The Anti-Thyroid Drugs Market

35. Anti-Thyroid Drugs Market High Potential Countries, Segments and Strategies

35.1 Anti-Thyroid Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Anti-Thyroid Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Anti-Thyroid Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer